We are live on ! Find out more
CDIO icon

Cardio Diagnostics
CDIO

35 hedge funds and large institutions have $55.2M invested in Cardio Diagnostics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

17% more funds holding

Funds holding: 30 → 35 (+5)

6% more capital invested

Capital invested by funds: $52M → $55.2M (+$3.22M)

12.56% less ownership

Funds ownership: 80.91% → 68.36% (-13%)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
YCM
Yakira Capital Management
Connecticut
+$1.98M
2
PC
Periscope Capital
Ontario, Canada
+$1.22M
3
MSU
Mizuho Securities USA
New York
+$532K
4
CCA
Castle Creek Arbitrage
Colorado
+$496K
5
SSA
Schonfeld Strategic Advisors
New York
+$426K

Top Sellers

Rank Fund Capital Flow
1
WAM
Weiss Asset Management
Massachusetts
-$2.48M
2
AA
AQR Arbitrage
Connecticut
-$6.55K
3
KIM
Karpus Investment Management
New York
-$3.87K

CDIO Hedge Fund Activity: Q2 2022 in Review

35 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q2 2022, worth a combined $55.2M — up 6.2% from $52M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CDIO positions and 0 closed out — a net gain of 5 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Yakira Capital Management, opening a new position worth an estimated $1.98M. The largest seller was Weiss Asset Management, cutting an estimated $2.48M.

  • 35 institutional investors held Cardio Diagnostics (CDIO) as of Q2 2022, up from 30 in Q1 2022.
  • Funds reported $55.2M of Cardio Diagnostics stock for Q2 2022, up 6.2% quarter-over-quarter.
  • 5 funds opened new Cardio Diagnostics positions in Q2 2022 and 0 closed out, a net change of +5 holders.
  • The largest Cardio Diagnostics buyer in Q2 2022 was Yakira Capital Management, an estimated $1.98M added.
  • The largest Cardio Diagnostics seller in Q2 2022 was Weiss Asset Management, an estimated $2.48M sold.

Based on aggregated 13F filings for Q2 2022.